First Tracks Biotherapeutics

First Tracks Biotherapeutics Assets per Share

The Total Assets per Share of First Tracks Biotherapeutics (TRAX) as of Oct 17, 2026 is 9.47 USD. In the previous year, Total Assets per Share was 12.66 USD — a change of -25.20% (lower).

Assets per Share

9.47USD

YoY

-25.20%

Last updated:

Total Assets per Share of First Tracks Biotherapeutics is 2025 9.47 USD. Total Assets per Share of First Tracks Biotherapeutics was 2024 12.66 USD. It decreases by -25.20% lower compared to the previous year.

The First Tracks Biotherapeutics Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2023
12.73 USD
Jan 1, 2024
12.66 USD
Jan 1, 2025
9.47 USD
The First Tracks Biotherapeutics Assets per Share history
YEARAssets per ShareYoY
9.47USD-25.20%
12.66USD-0.50%
12.73USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

First Tracks Biotherapeutics Stock analysis

What does First Tracks Biotherapeutics do? First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company based in San Diego, United States, developing immunology therapeutics for autoimmune and inflammatory diseases. The company focuses on innovative treatments including ANB033, a novel anti-CD122 antagonist targeting IL-15 and IL-2 receptors, Rosnilimab, which selectively depletes pathogenic T cells, and ANB101, a BDCA2-modulating antibody targeting plasmacytoid dendritic cells. Founded in 2019, it operates in the United States with a focus on advancing therapies for complex immune conditions. First Tracks Biotherapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about First Tracks Biotherapeutics stock

Total Assets per Share of First Tracks Biotherapeutics is 9.47 USD in 2025.

Total Assets per Share of First Tracks Biotherapeutics changed from 12.66 USD to 9.47 USD, representing a -25.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share First Tracks Biotherapeutics since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — First Tracks Biotherapeutics

All Key Metrics — First Tracks Biotherapeutics